The PE Ratio as of December 2024 (TTM) for MAIA Biotechnology, Inc. (MAIA) is -1.49

According to MAIA Biotechnology, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.49. This represents a change of -42.87% compared to the average of -2.61 of the last 4 quarters.

MAIA Biotechnology, Inc. (MAIA) Historical PE Ratio (quarterly & annually)

How has MAIA PE Ratio performed in the past?

The mean historical PE Ratio of MAIA Biotechnology, Inc. over the last ten years is -4.17. The current -1.49 PE Ratio has changed 3.48% with respect to the historical average. Over the past ten years (40 quarters), MAIA's PE Ratio was at its highest in in the December 2023 quarter at -0.79. The PE Ratio was at its lowest in in the September 2020 quarter at -16.18.

MAIA Biotechnology, Inc. (MAIA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of MAIA Biotechnology, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MAIA Biotechnology, Inc. (MAIA) Average PE Ratio

How has MAIA PE Ratio performed in the past?

The current PE Ratio of MAIA Biotechnology, Inc. (MAIA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

MAIA Biotechnology, Inc. (MAIA) PE Ratio vs. Peers

How is MAIA’s PE Ratio compared to its peers?

MAIA Biotechnology, Inc.’s PE Ratio is greater than Lineage Cell Therapeutics, Inc. (-5.04), greater than Armata Pharmaceuticals, Inc. (-1.78), greater than Frequency Therapeutics, Inc. (-3.96), less than Portage Biotech Inc. (-0.08), less than AgeX Therapeutics, Inc. (-1.48), greater than Larimar Therapeutics, Inc. (-3.72), less than Graphite Bio, Inc. (-0.13), less than Lyra Therapeutics, Inc. (-0.12), greater than Genelux Corporation (-2.98), less than Comera Life Sciences Holdings, Inc. (-0.00), greater than Dyadic International, Inc. (-8.11), less than Cingulate Inc. (-0.00), less than Monopar Therapeutics Inc. (-0.59), greater than Transgene SA (-1.81), greater than Eupraxia Pharmaceuticals Inc. (-6.61), greater than Champions Oncology, Inc. (-178.90), less than Lumos Pharma, Inc. (-1.04), less than Roivant Sciences Ltd. (1.83), less than Field Trip Health & Wellness Ltd. (-0.34), less than Telix Pharmaceuticals Limited (267.93), greater than Nautilus Biotechnology, Inc. (-3.09),

Build a custom stock screener for MAIA Biotechnology, Inc. (MAIA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MAIA Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MAIA Biotechnology, Inc. (MAIA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MAIA Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.